US FDA Transparency Win: Sponsors Know More Product-Specific Guidances Coming, Requests Fall

 
• By Derrick Gingery
transparency
Generic drug sponsors use the anticipated PSG list to validate development portfolios. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics